VRx insights TexturesIconsImagesFontsColorGradientsBordersHelpSitemap insights.vrx.palo-alto.ca.us
Typhoid and Ascorbate therapy

Typhoid and Ascorbate therapy

"I could find no mainstream medical researcher who has performed ANY clinical studies on ANY infectious disease with vitamin C does that approached those used by Klenner. Using a small enough dose of any therapeutic agent will demonstrate little or no effect on an infection or disease process. Klenner would often use daily doses of vitamin C on a patient that would be as much as 10,000 times more than the daily doses used in some of the many clinical studies in the literature." (p 28-29)

Because there are few families that will not be affected by serious infectious illness, the individual topics Dr. Levy addresses (in Chapter 2, constituting 130 pages) are especially important. These include measles, mumps, viral encephalitis, herpes, mononucleosis, viral pneumonia, chickenpox, Ebola, and of course influenza. He has included a fairly lengthy section on AIDS. Rabies is an intriguing entry, even to those already willing to concede that vitamin C is an effective antiviral.

Non-viral diseases discussed include diphtheria, tuberculosis (in considerable detail), strep, brucellosis, typhoid, dysentery, malaria, trichinosis, and the always-controversial subjects of tetanus and pertussis. " Vitamin C, Infectious Diseases, and Toxins: Curing the Incurable, by Thomas E. Levy, M.D., J.D.

See also

Bhatnagar, R. and S. Batra. (2001) Anthrax toxin. Critical Reviews in Microbiology 27(3):167-200.

Brossier, F. and M. Mock. (2001) Toxins of bacillus anthracis. Toxicon: Official Journal of the International Society on Toxinology 39(11):1747-1755.

Casciari, J., N. Riordan, T. Schmidt, X. Meng, J. Jackson, and H. Riordan. (2001) Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. British Journal of Cancer 84(11):1544-1550.

Cathcart, R. (1981) Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy. Medical Hypotheses 7(11):1359-1376.

Dey, P. (1966) Efficacy of vitamin C in counteracting tetanus toxicity. Naturwissenschaften 53(12):310.

Henderson, D., T. Inglesby, J. Bartlett, M. Ascher, E. Eitzen, P. Jahrling, J. Hauer, M. Layton, J. McDade, M. Osterholm, T. O'Toole, G. Parker, T. Perl, P. Russell, and K. Tonat. (1999) Smallpox as a biological weapon. Medical and public health management. The Journal of the American Medical Association 281(22):2127-2137.

Inglesby, T., D. Henderson, J. Bartlett, M. Ascher, E. Eitzen, A. Friedlander, J. Hauer, J. McDade, M. Osterholm, T. O'Toole, G. Parker, T. Perl, P. Russell, and K. Tonat. (1999) Anthrax as a biological weapon. Medical and public health management. The Journal of the American Medical Association 281(18):1735-1745.

Jungeblut, C. and R. Zwemer. (1935) Inactivation of diphtheria toxin in vivo and in vitro by crystalline vitamin C (ascorbic acid). Proceedings of the Society for Experimental Biology and Medicine 32:1229-1234.

Klenner, F. (1949) The treatment of poliomyelitis and other virus diseases with vitamin C. Southern Medicine & Surgery 111(7):209-214.

Klenner, F. (1951) Massive doses of vitamin C and the virus diseases. Southern Medicine & Surgery 103(4):101-107.

Klenner, F. (1953) The use of vitamin C as an antibiotic. Journal of Applied Nutrition 6:274-278.

Klenner, F. (1954) Recent discoveries in the treatment of lockjaw with vitamin C and Tolserol. Tri-State Medical Journal pp. 7-11.

Klenner, F. (1971) Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. Journal of Applied Nutrition 23(3&4):61-88.

Klenner, F. (1974) Significance of high daily intake of ascorbic acid in preventive medicine. Journal of the International Academy of Preventive Medicine 1(1):45-69.

Kligler, I. and H. Bernkopf. (1937) Inactivation ofvaccinia virus by ascorbic acid and glutathione. Nature 139:965-966.

Lane, J., F. Ruben, J. Neff, and J. Millar. (1969) Complications of smallpox vaccination, 1968. National surveillance in the United States. The New England Journal of Medicine 281(22):1201-1208.

Mack, T. (1972) Smallpox in Europe, 1950-1971. The Journal of Infectious Diseases 125(2):161-169.

Mack, T., D. Thomas, and M. Muzaffar Khan. (1972) Epidemiology of smallpox in West Pakistan. II. Determinants of intravillage spread other than acquired immunity. American Journal of Epidemiology 95(2):169-177.

Mock, M. and A Fouet. (2001) Anthrax. Annual Review of Microbiology 55:647-671.

Ormerod, M., B. Unkauf, and F. White. (1937) A further report on the ascorbic acid treatment of whooping cough. Canadian Medical Association Journal 37(3):268-272.

Otani, T. (1936) On the vitamin C therapy of pertussis. Klinische Wochenschrift 15(51):1884-1885.

Otani, T. (1939) Influence of vitamin C (L-ascorbic acid) upon the whooping cough bacillus and its toxin. Oriental Journal of Diseases of Infants 25:1-4.

Stearn, E. and A. Stearn. (1945) The Effect of Smallpox on the Destiny of the Amerindian. Boston, MS: Bruce Humphries.